Home > News > Nanotechnology Institute Signs GlaxoSmithKline
April 1st, 2004
Nanotechnology Institute Signs GlaxoSmithKline
Abstract:
The Nanotechnology Institute (NTI), a comprehensive model for the development of nanotechnology-driven, real-world applications, has signed GlaxoSmithKline (GSK) as a corporate member. This partnership reflects the NTI's efforts to commercialize the basic research done through the Institute's four core research teams. It also matches GSK's efforts to identify technologies that enable new product and research methodologies.
Source:
PrimeZone
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
Single atoms show their true color July 5th, 2024
New method cracked for high-capacity, secure quantum communication July 5th, 2024
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |